Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.
Cui
Jing
J
Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Saevarsdottir
Saedis
S
Thomson
Brian
B
Padyukov
Leonid
L
van der Helm-van Mil
Annette H M
AH
Nititham
Joanne
J
Hughes
Laura B
LB
de Vries
Niek
N
Raychaudhuri
Soumya
S
Alfredsson
Lars
L
Askling
Johan
J
Wedrén
Sara
S
Ding
Bo
B
Guiducci
Candace
C
Wolbink
Gert Jan
GJ
Crusius
J Bart A
JB
van der Horst-Bruinsma
Irene E
IE
Herenius
Marieke
M
Weinblatt
Michael E
ME
Shadick
Nancy A
NA
Worthington
Jane
J
Batliwalla
Franak
F
Kern
Marlena
M
Morgan
Ann W
AW
Wilson
Anthony G
AG
Isaacs
John D
JD
Hyrich
Kimme
K
Seldin
Michael F
MF
Moreland
Larry W
LW
Behrens
Timothy W
TW
Allaart
Cornelia F
CF
Criswell
Lindsey A
LA
Huizinga
Tom W J
TW
Tak
Paul P
PP
Bridges
S Louis
SL
Toes
Rene E M
RE
Barton
Anne
A
Klareskog
Lars
L
Gregersen
Peter K
PK
Karlson
Elizabeth W
EW
Plenge
Robert M
RM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology; D004185:Disability Evaluation; D005260:Female; D020022:Genetic Predisposition to Disease; D006304:Health Status; D006801:Humans; D007391:International Cooperation; D017493:Leukocyte Common Antigens / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D017493:Leukocyte Common Antigens; C516769:PTPRC protein, human